+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Failure of interferon to prevent recurrent hepatitis b infection in hepatic allograft



Failure of interferon to prevent recurrent hepatitis b infection in hepatic allograft



Hepatology 8(5): 1287




(PDF emailed within 0-6 h: $19.90)

Accession: 028322734

Download citation: RISBibTeXText

DOI: 10.1016/S0025-6196(12)65733-4


Related references

Failure of interferon to prevent recurrent hepatitis B infection in hepatic allograft. Mayo Clinic Proceedings 64(4): 429-432, 1989

Recurrent hepatitis B infection in hepatic allograft. Mayo Clinic Proceedings 64(5): 597-597, 1989

Long-term application of human polyclonal hepatitis-B immunoglobulin to prevent hepatic allograft infection. Netherlands Journal of Medicine International Edition 43(1-2): 74-82, 1993

Follow-up of recurrent hepatitis B and delta infection in liver allograft recipients after treatment with recombinant interferon-alpha. Journal of Hepatology 13(3): 339-346, 1991

Failure of ganciclovir prophylaxis to prevent allograft reinfection following orthotopic liver transplantation for chronic hepatitis B infection. Liver Transplantation and Surgery 2(5): 370-374, 1996

Long-term application of human polyclonal hepatitis-B immunoglobulin to prevent hepatic allograft infection. A review of the literature and presentation of five cases. Netherlands Journal of Medicine 43(1-2): 74-82, 1993

Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection. Liver Transplantation 10(12): 1497-1503, 2004

Recurrent hepatitis C infection following orthotopic liver transplantation is predicted by posttransplant serum and hepatic allograft viral titers. Transplantation Proceedings 29(7): 2839-2840, 1997

Clinical outcome and pathological correlation following interferon alpha 2B treatment of recurrent hepatitis B and hepatitis C in orthotopic liver allograft recipients. Hepatology 20(4 PART 2): 130A, 1994

Follow up of recurrent hepatitis b and delta in liver allograft recipients treated with interferon alpha. Journal of Hepatology 11(SUPPL 2): S35, 1990

De novo hepatocellular carcinoma in a hepatic allograft with recurrent hepatitis C cirrhosis. Liver Transplantation and Surgery 5(1): 81-82, 1999

Failure of interferon to prevent disease progression and liver cancer in hepatitis C virus infection: proof of absence or absence of proof?. Gastroenterology 138(2): 777-779, 2009

Early treatment of acute hepatitis C infection with monotherapy interferon alfa is effective to prevent development of chronic hepatitis. Gastroenterology 120(5 Supplement 1): A 380-A 381, April, 2001

The influence of hepatitis B and hepatitis C virus infection in the recipient on late renal allograft failure. Nephrology, Dialysis, Transplantation 19 Suppl 3: Iii72-6, 2004

Failure of acyclovir to prevent cytomegalovirus infection in renal allograft recipients. Transplant International 6(5): 285-289, 1993